Kulmbach (www.aktiencheck.de) - Tilray-Aktienanalyse von "Der Aktionär":
Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Tilray Brands Inc. (ISIN:…
Tilray Brands shares tumble on earnings miss, guidance cut…
Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter…
Tilray Brands (TLRY) delivered earnings and revenue surprises of 100% and 5.93%, respectively, for the quarter ended February 2024. Do…
New York (www.aktiencheck.de) - Tilray-Aktienanalyse von Alliance Global Partners:
Die Analysten von Alliance Global Partners erhöhen das Kursziel für die Aktie…
Kulmbach (www.aktiencheck.de) - Tilray-Aktienanalyse von "Der Aktionär":
Florian Söllner vom Anlegermagazin "Der Aktionär" nimmt im Interview mit "Der Aktionär TV" die…
Youll need to be patient to gain the most from this investment.…
Cannabis stocks are surging, helped by positive regulatory steps in the United States. Tilray Brands (NASDAQ: TLRY) stock jumped to…
Tilray Brands stock just isnt worth the risk.…
Cronos Group (CRON), Curaleaf Holdings (CURLF), and Tilray Brands (TLRY) stand out as promising cannabis stocks with strong financials and…
^CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.
(?Tilray" …
^CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) Tilray Brands, Inc.(?Tilray" oder das …
^CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.(?Tilray" oder das?Unternehmen") (Nasdaq: TLRY; TSX: TLRY), ein führendesglobales Cannabis-…
Tilray Brands has been exploring growth opportunities beyond just the U.S. market.…
Tilray Brands has been exploring growth opportunities beyond just the U.S. market.…
Die Freigabe von Cannabis in Deutschland eröffnet neue Möglichkeiten für Tilray auf dem potenziellen 3-Milliarden-Dollar-Markt für medizinische Produkte Markt für…
^Die Freigabe von Cannabis in Deutschland eröffnet neue Möglichkeiten für Tilray
auf dem…
Im Verlauf der letzten Woche verzeichnete die Aktie von Tilray Brands, Inc. einen leichten Rückgang von 0,5% und steht nun…
It has a successful diversification play in hand and big catalysts looming, but theres plenty of risk.…
…
Investors have punished Tilrays stock, which is down more than 90% in three years.…
Investors have punished Tilrays stock, which is down more than 90% in three years.…
With its stock struggling mightily over the past few years, Tilray Brands needs a catalyst.…
…
With its stock struggling mightily over the past few years, Tilray Brands needs a catalyst.…
Itll take more than access to big markets to make their shares soar.…
The business is bigger, but its not necessarily any better.…
…
PALM BEACH, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A few years…
…
Can Tilray stock deliver on its promise of positive free cash flow in 2024?…
…
TLRY earnings call for the period ending December 31, 2023.…
…
Tilray Inc (NASDAQ:TLRY) reported a narrowed net loss and a significant increase in net revenue for the second quarter ending…
Kulmbach (www.aktiencheck.de) - Tilray-Aktienanalyse von "Der Aktionär":
Philipp Schleu vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Cannabis group Tilray Brands second-quarter profit slips despite record revenue…
…
Kulmbach (www.aktiencheck.de) - Tilray-Aktienanalyse von "Der Aktionär":
Philipp Schleu vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Which of these top Canadian licensed producers is the better buy?…
…
Which of these top Canadian licensed producers is the better buy?…
NEW YORK and LEAMINGTON, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”)…
Should you go with the U.S.-focused cannabis business or the company with broader diversification?…
Theres some reason to be bullish on the stock next year.…
…
Theres some reason to be bullish on the stock next year.…
The cannabis industry is maturing, but after a tough 2023 challenges remain for companies and investors.In Canada, the sector continues…
2023 has been yet another year of uncertainty for the cannabis industry, with little progress in terms of legislative clarity…
The cannabis industry faced similar obstacles in 2023 as it did in 2022, with a lack of reform both in…